The Joint Committee on Vaccination and Immunisation (JCVI) has issued new advice on the use of the Oxford-AstraZeneca vaccine, due to concerns over a very rare risk of blood clots.
Report by Jonesia.
Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
